Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer

HIGHLIGHTS

• who: Bo Liu from the Nanjing University School of Medicine, China have published the research work: Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer, in the Journal: (JOURNAL)
• what: In the study , the differences in lung microbiota and metabolites between LC patients and patients with non-lung cancer were explored by 16S rRNA amplicon sequencing and metagenomics.
• how: The results indicated that lung microbiota and metabolites might play key roles in the development of LC and the altered metabolites and microbiota might have the potential to be clinical diagnostic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.